Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

View slides from this presentation

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.

 

Related resources

#
Self-care and resilience: Practice what you teach
While healthcare professionals often encourage their patients to learn and…
Learn more
#
Anxiety in youth: A family-based treatment approach
Explore the importance of psychoeducation to prepare young patients and…
Learn more
#
Treating substance use disorders and PTSD: Clinical considerations
Explore the unique challenges of treating patients with co-occurring PTSD…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.